Matches in Nanopublications for { ?s ?p "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP765073.RAo9dWsKfXreXj0Cu88Kaji6BAt69XJaeQWilp63l4fGs130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765073.RAo9dWsKfXreXj0Cu88Kaji6BAt69XJaeQWilp63l4fGs130_provenance.
- NP644658.RAaR8X7C_HHh7E4KlTS52G6Y2V0uwV4TZO135uuNpEOpo130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644658.RAaR8X7C_HHh7E4KlTS52G6Y2V0uwV4TZO135uuNpEOpo130_provenance.
- NP535216.RA90-kK6w6oxfitdJFamSC3F0ahEz1cgCAfMH38v6nJqQ130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535216.RA90-kK6w6oxfitdJFamSC3F0ahEz1cgCAfMH38v6nJqQ130_provenance.
- assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP419645.RAdgbMqHy5ZpdWg4uJG1rRSVWxlWl4LXCTMJigrgDOXqY130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419645.RAdgbMqHy5ZpdWg4uJG1rRSVWxlWl4LXCTMJigrgDOXqY130_provenance.
- NP576844.RAMcm6eFZDkO_OVBa54-n1eHAUVLGpAa0_LmN7pyq9YZ8130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576844.RAMcm6eFZDkO_OVBa54-n1eHAUVLGpAa0_LmN7pyq9YZ8130_provenance.
- NP419741.RAiH5yUqDDHtfmVRgAMwqBfvGjIfM6PrTtt1yQgJRH9EM130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419741.RAiH5yUqDDHtfmVRgAMwqBfvGjIfM6PrTtt1yQgJRH9EM130_provenance.
- NP485418.RAF9rhooaF_tL-RPAQkvj_XUJrm_OFnVOgQqYtm4ohPDs130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485418.RAF9rhooaF_tL-RPAQkvj_XUJrm_OFnVOgQqYtm4ohPDs130_provenance.
- NP485416.RAzDbi2-suLlR4advQF7N5cTh0o7CWIis8lY3tgzhQpjQ130_assertion description "[In contrast to GATA-6, we found upregulated cyclin-dependent kinase inhibitor p21 and proliferation marker Ki67 in adrenocortical carcinomas indicating that GATA-6 is not linked to cell proliferation in human adrenal tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485416.RAzDbi2-suLlR4advQF7N5cTh0o7CWIis8lY3tgzhQpjQ130_provenance.